Fennec Pharmaceuticals Inc. SEC filings FENC

Fennec Pharmaceuticals Inc. has 853 filings in SEC EDGAR's recent list, going back to Dec 10, 2002. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 17, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Mar 27, 2026 Dec 31, 2025
10-K Annual report Mar 26, 2025 Dec 31, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
10-K Annual report Feb 28, 2022 Dec 31, 2021
10-K Annual report Mar 30, 2021 Dec 31, 2020
10-K Annual report Feb 14, 2020 Dec 31, 2019
10-K Annual report Mar 15, 2019 Dec 31, 2018
10-K Annual report Mar 28, 2018 Dec 31, 2017
10-K Annual report Mar 29, 2017 Dec 31, 2016
10-K Annual report Mar 28, 2016 Dec 31, 2015
10-K Annual report Mar 31, 2015 Dec 31, 2014
10-K/A Amended annual report Apr 8, 2014 Dec 31, 2013
10-K/A Amended annual report Apr 2, 2014 Dec 31, 2013
10-K Annual report Mar 31, 2014 Dec 31, 2013
10-K Annual report Apr 1, 2013 Dec 31, 2012
10-K Annual report Mar 27, 2012 Dec 31, 2011
10-K Annual report Mar 31, 2011 Dec 31, 2010
10-K/A Amended annual report Feb 7, 2011 Dec 31, 2009
10-K Annual report Mar 31, 2010 Dec 31, 2009
10-K Annual report Mar 30, 2009 Dec 31, 2008
10-K Annual report Mar 28, 2008 Dec 31, 2007
ARS Annual report to shareholders Apr 4, 2007 Dec 31, 2006
20-F Annual report (foreign issuer) Apr 2, 2007 Dec 31, 2006
20-F Annual report (foreign issuer) Mar 31, 2006 Dec 31, 2005
20-F Annual report (foreign issuer) Mar 31, 2005 Dec 31, 2004

Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
FENC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Research Triangle Park, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1211583
Former names
ADHEREX TECHNOLOGIES INC (until Aug 14, 2014)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.